About OPKO Health Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.opko.com/
Frequently Asked Questions
What is the 52-week range for OPK?
The 52-week high is $1.75 and the 52-week low is $0.98.
What is the P/E ratio for OPK?
The P/E ratio data is currently unavailable.
What is the dividend yield for OPK?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -5.88%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -23.93%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.76.
Analyst Recommendation Trends
Wall Street analyst consensus for OPK over the last few months:
Latest OPK News
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
OPKO Health eyes growth from RAYALDEE, partner revenues and a leaner BioReference, while pipeline and reimbursement risks remain key concerns.
OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?
OPKO Health is gaining on pharmaceutical growth, a broad clinical pipeline, strategic partnerships and fresh non-dilutive financing.
5 Undervalued Oncology Stocks Wall Street Is Overlooking
Oncology spending may hit $441B by 2029 as growth slows from genericsâsee 5 underappreciated cancer stocks with catalysts and upside. Click for the picks.
The Bull Case For OPKO Health (OPK) Could Change Following New Mazdutide Royalty-Backed Financing Strategy
Earlier this month, OPKO Health expanded its financing relationship with HealthCare Royalty by issuing US$125 million in senior secured notes backed by future mazdutide royalty payments from China, allowing it to raise capital without issuing new shares and with total repayments capped at 1.5 times the amount received. This royalty-backed financing structure highlights how OPKO Health is using its metabolic therapy partnerships to access non-dilutive funding while preserving potential...
OPKO Health (OPK) Cashes In A Future Royalty Stream Early
On August 13, OPKO Health (NASDAQ:OPK) expanded its financing relationship with HealthCare Royalty, a business of KKR, issuing an additional $125 million in senior secured notes secured by the royalty stream tied to mazdutide, the GLP-1 drug OPKO licensed to Eli Lilly and now collects royalties on in China. The notes mature in 2044, matching […]
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months
OPKO Health (NASDAQ:OPK) outlined a strategy to shift its business mix toward therapeutics while continuing to streamline its diagnostics operations, with management highlighting a pipeline of early-stage clinical programs, external collaborations and capital available to fund development. Speaking
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that Elias A. Zerhouni, M.D., President and Vice Chairman, and Adam Logal, Senior Vice President and Chief Financial Officer, will participate in the Wells Fargo 21st Annual Healthcare Conference at the Encore Boston Harbor, including a fireside chat on Thursday, Sep
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-24 | Rubin Steven D | -53,266 | $1.22 | $64,985 |
| 2026-07-24 | Logal Adam | -53,266 | $1.22 | $64,985 |
| 2026-06-18 | Lachman Prem A | +30,000 | - | - |
| 2026-06-18 | Yu Alice Lin-Tsing | +30,000 | - | - |
| 2026-06-18 | UPPALURI SUBBARAO V | +80,000 | - | - |
| 2026-06-18 | PAGANELLI JOHN A | +30,000 | - | - |
| 2026-06-18 | PFENNIGER RICHARD C JR | +60,000 | - | - |
| 2026-06-18 | MEDEL ROGER MD | +30,000 | - | - |
| 2026-03-20 | PAGANELLI JOHN A | +10,000 | $1.135 | $11,350 |
| 2026-03-18 | UPPALURI SUBBARAO V | +50,000 | - | - |
| 2025-11-21 | FROST PHILLIP MD ET AL | +192,870 | $1.335 | $257,481 |
| 2025-11-21 | FROST PHILLIP MD ET AL | +191,490 | $1.33 | $254,682 |
| 2025-11-21 | FROST PHILLIP MD ET AL | +89,375 | $1.325 | $118,422 |
| 2025-11-21 | FROST PHILLIP MD ET AL | +3,894 | $1.32 | $5,140 |
| 2025-11-21 | FROST PHILLIP MD ET AL | +102,371 | $1.3 | $133,082 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +13,664 | $1.35 | $18,446 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +1,757 | $1.345 | $2,363 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +24,579 | $1.34 | $32,936 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +161,818 | $1.335 | $216,027 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +211,948 | $1.33 | $281,891 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +47,105 | $1.325 | $62,414 |
| 2025-11-20 | FROST PHILLIP MD ET AL | +119,129 | $1.32 | $157,250 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +155,496 | $1.32 | $205,255 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +198,904 | $1.315 | $261,559 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +66,504 | $1.31 | $87,120 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +12,993 | $1.305 | $16,956 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +30,082 | $1.3 | $39,107 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +21,236 | $1.295 | $27,501 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +300 | $1.29 | $387 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +58,160 | $1.285 | $74,736 |
| 2025-11-19 | FROST PHILLIP MD ET AL | +36,325 | $1.28 | $46,496 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +33,572 | $1.29 | $43,308 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +1 | $1.2859 | $1 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +83,556 | $1.285 | $107,369 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +428 | $1.2847 | $550 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +69,728 | $1.28 | $89,252 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +212,608 | $1.275 | $271,075 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +1,772 | $1.27 | $2,250 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +15,000 | $1.265 | $18,975 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +46,700 | $1.26 | $58,842 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +66,635 | $1.255 | $83,627 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +49,590 | $1.25 | $61,988 |
| 2025-11-18 | FROST PHILLIP MD ET AL | +410 | $1.245 | $510 |
| 2025-10-31 | FROST PHILLIP MD ET AL | +150,000 | $1.4229 | $213,435 |